-
Roche Diagnostics Recalls CoaguChek XS PT Test Strips Due to Inaccurate INR Test Results
-
ALERT: AAPM&R Analyzing Final 2019 Medicare Physician Fee Schedule Released
-
Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)
-
AAPM&R Collaborating with ABPMR and AAP on the Current ACGME's Program Requirements for Pain Medicine
-
Request for Feedback: Definition of a Rehabilitation Physician
-
Help CMS Improve the Quality Payment Program by Participating in User Research
-
An MOC Update and Request
-
Amy J. Houtrow, MD, PhD, MPH, FAAPMR, Elected to the National Academy of Medicine: In the News, October 17, 2018
-
Mary E. (Mamie) Air, MD, FAAPMR, Appointed Chief of Physical Medicine: In the News, October 17, 2018
-
Drs. Charuk, Chiappini, Jani, Jones, and Martínez-Silvestrini: In the News, October 10, 2018
-
Look for Your October/November Issue of The Physiatrist
-
A WIN FOR PM&R: Sports Medicine Licensure Clarity Act to Become Law
-
CMS to Conduct Field Testing for 13 Cost Measures
-
Now Available: Innovations Influencing PM&R Supplement and SAE-P
-
Samuel Dona, Jr., MD, FAAPMR Joins PM&R Team: In the News, October 3, 2018
-
Endo Pharmaceuticals Issues Voluntary Nationwide Recall for Two Lots of Robaxin® 750mg Tablets 100 Count Bottle Packs Due to Incorrect Daily Dosing Information on Label
-
Anthony DiGirolamo, DO, FAAPMR Joins PM&R Team: In the News, September 26, 2018
-
AAPM&R Provides Voice for People with Chronic Diseases and Disabilities with NHC
-
ALERT: Ultrasound of Extremity Practice Expense Reimbursement Change
-
FDA alerts consumers of BioLyte Laboratories voluntary recall of NeoRelief